glp-1 agonists and sglt2 inhibitors combination Perspectives in weight control in diabetes – GLP-1–glucagon dual agonism SGLT-2 Inhibitors and GLP-1 Agonists:
Description
Zhang WJ, Tan YF, Yue JT, Vranic M, Wojtowicz JM
H., Lim, A
Moreover, studies highlight its potential cardiovascular benefits
10.1089/thy.2023.0530 22 FemminellaG
What was the design of this colorectal cancer risk study
